Lobe Sciences Ltd. (CSE:LOBE)

Revenue by Product

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Aug 31, 2024	Aug 31, 2023	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2015
New Medicines	136.21K
New Medicines Growth	-83.80%

Revenue by Geography

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	FY 2024	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Aug 31, 2024	Aug 31, 2023	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019	Aug 31, 2015
Canada	136.21K
Canada Growth	-83.80%